Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genotypification and Predisposing Factors in Human Papilloma Virus Infection and Its Association With the Carbohydrate Antigen (CA-125) Tumoral Marker

NCT01924117 is registered in ClinicalTrials.gov with Materno-Perinatal Hospital of the State of Mexico as lead sponsor.

NCT NCT01924117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01924117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genotypification and Predisposing Factors in Human Papilloma Virus Infection and Its Association With the Carbohydrate Antigen (CA-125) Tumoral Marker
Lead sponsor
Materno-Perinatal Hospital of the State of Mexico
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2011
Completion date
October 31, 2011
Enrollment
129 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

intraepithelial neoplasia